# OnCo record toby-urine-mced (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/toby-urine-mced/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "toby-urine-mced" ;
  schema:name "TOBY urine multi-cancer early detection test"@en ;
  schema:description "A urine test in development from TOBY, Inc. that looks for cancer-linked chemicals in urine; it received FDA Breakthrough Device designation in April 2026, and its only performance figures are the company's own."@en ;
  schema:url <https://onco.cc/drugs/toby-urine-mced/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.urologytimes.com/view/fda-grants-breakthrough-device-designation-to-urine-based-multi-cancer-early-detection-test> ;
  onco:status "emerging" ;
  onco:tag "test", "mced", "evidence:insufficient" ;
  onco:modality "Multi-cancer early detection urine test in development (volatile organic compounds, spectroscopy)" ;
  schema:alternateName "TOBY" ;
  onco:related <https://onco.cc/drugs/gagome-mced-test/>, <https://onco.cc/drugs/n-nose/> ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/rcc/> ;
  onco:technologies <https://onco.cc/technologies/mced/>, <https://onco.cc/technologies/liquid-biopsy/> .